Literature DB >> 31320464

Comparison of CSF and MRI Findings among Neonates and Infants with E coli or Group B Streptococcal Meningitis.

S F Kralik1,2, M K Kukreja3, M J Paldino3, N K Desai3, J G Vallejo4.   

Abstract

BACKGROUND AND
PURPOSE: Group B Streptococcus and Escherichia coli (E coli) are the 2 most common causes of bacterial meningitis in neonates. The purpose of this study was to determine whether CSF and/or MR imaging findings differ between infants with group B streptococcal or E coli meningitis.
MATERIALS AND METHODS: A retrospective review was performed among neonates (younger than 28 days) and infants (younger than 120 days) with proved group B streptococcal (n = 57) or E coli meningitis (n = 50). A CSF or blood culture positive for Streptococcus or E coli and an elevated CSF white blood cell count were used as the criterion standard. Independent, blinded review of brain MRIs obtained within 21 days of presentation were performed by 2 board-certified neuroradiologists. CSF laboratory values and MR imaging findings were compared between the groups.
RESULTS: There was no statistically significant difference between the mean age at presentation for patients with group B streptococcal (40 days; range, 2-111 days) versus patients with E coli meningitis (31 days; range, 12-115 days) (P = .18). There was no statistically significant difference in the CSF white blood cell count, glucose, or protein. There was a significant difference between group B streptococcal and E coli meningitis in the frequency of hydrocephalus (0% versus 22%, P = .001) and infarct (40% versus 14%; P = .038), respectively. There was no statistically significant difference in leptomeningeal enhancement, cerebritis, ventriculitis, abscess/granuloma, subdural effusion, extra-axial purulent material, intraventricular purulent material, hemorrhage, and sinus thrombosis.
CONCLUSIONS: Although neonates and infants with group B streptococcal or E coli meningitis had similar age and CSF laboratory values, patients with group B streptococcal meningitis more frequently demonstrated infarcts, while those with E coli meningitis more frequently had early onset of hydrocephalus.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 31320464      PMCID: PMC7048479          DOI: 10.3174/ajnr.A6134

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  17 in total

Review 1.  Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention.

Authors:  Kwang S Kim
Journal:  Curr Opin Infect Dis       Date:  2012-06       Impact factor: 4.915

2.  Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants.

Authors:  Lori A Kestenbaum; Jessica Ebberson; Joseph J Zorc; Richard L Hodinka; Samir S Shah
Journal:  Pediatrics       Date:  2010-01-11       Impact factor: 7.124

3.  Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease.

Authors:  Carol J Baker; Carrie L Byington; Richard A Polin
Journal:  Pediatrics       Date:  2011-08-01       Impact factor: 7.124

4.  Analysis of clinical outcomes in pediatric bacterial meningitis focusing on patients without cerebrospinal fluid pleocytosis.

Authors:  Wen-Li Lin; Hsin Chi; Fu-Yuan Huang; Daniel Tsung-Ning Huang; Nan-Chang Chiu
Journal:  J Microbiol Immunol Infect       Date:  2014-11-01       Impact factor: 4.399

5.  The Epidemiology, Management, and Outcomes of Bacterial Meningitis in Infants.

Authors:  Lynda Ouchenir; Christian Renaud; Sarah Khan; Ari Bitnun; Andree-Anne Boisvert; Jane McDonald; Jennifer Bowes; Jason Brophy; Michelle Barton; Joseph Ting; Ashley Roberts; Michael Hawkes; Joan L Robinson
Journal:  Pediatrics       Date:  2017-06-09       Impact factor: 7.124

Review 6.  Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy.

Authors:  Kelly S Doran; Victor Nizet
Journal:  Mol Microbiol       Date:  2004-10       Impact factor: 3.501

7.  Brain magnetic resonance imaging of infants with bacterial meningitis.

Authors:  Carlos R Oliveira; Michael C Morriss; John G Mistrot; Joseph B Cantey; Christopher D Doern; Pablo J Sánchez
Journal:  J Pediatr       Date:  2014-04-13       Impact factor: 4.406

8.  Severe, widespread vasculopathy in late-onset group B streptococcal meningitis.

Authors:  Shigeo Iijima; Masami Shirai; Takehiko Ohzeki
Journal:  Pediatr Int       Date:  2007-12       Impact factor: 1.524

9.  Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis.

Authors:  Kelly S Doran; George Y Liu; Victor Nizet
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 10.  The role of the nitric oxide pathway in brain injury and its treatment--from bench to bedside.

Authors:  P S Garry; M Ezra; M J Rowland; J Westbrook; K T S Pattinson
Journal:  Exp Neurol       Date:  2014-10-29       Impact factor: 5.330

View more
  3 in total

1.  Expert consensus on the clinical practice of neonatal brain magnetic resonance imaging.

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15

Review 2.  Group B Streptococcal Neonatal Meningitis.

Authors:  Teresa Tavares; Liliana Pinho; Elva Bonifácio Andrade
Journal:  Clin Microbiol Rev       Date:  2022-02-16       Impact factor: 50.129

3.  Colibactin in avian pathogenic Escherichia coli contributes to the development of meningitis in a mouse model.

Authors:  Peili Wang; Jiaxiang Zhang; Yanfei Chen; Haoran Zhong; Heng Wang; Jianji Li; Guoqiang Zhu; Pengpeng Xia; Luying Cui; Jun Li; Junsheng Dong; Qingqing Gao; Xia Meng
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.